Bellevue Asset Management’s NeoGenomics NEO Stock Holding History

Bellevue Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-112	Closed	-$1.06K	–	483
2025 Q1	$1.06K	Hold	112	–	–	﹤0.01%	470
2024 Q4	$1.85K	Hold	112	–	–	﹤0.01%	450
2024 Q3	$1.65K	Hold	112	–	–	﹤0.01%	435
2024 Q2	$1.55K	Hold	112	–	–	﹤0.01%	436
2024 Q1	$1.76K	Buy	112 +32	+40%	+$494	﹤0.01%	425
2023 Q4	$1.29K	Buy	+80	New	+$1.31K	﹤0.01%	438
2023 Q3	–	Sell	-80	Closed	-$1.28K	–	470
2023 Q2	$1.28K	Hold	80	–	–	﹤0.01%	451
2023 Q1	$1.39K	Buy	+80	New	+$1.14K	﹤0.01%	460
2022 Q1	–	Sell	-92	Closed	-$3K	–	559
2021 Q4	$3K	Sell	92 -8	-8%	-$313	﹤0.01%	449
2021 Q3	$5K	Hold	100	–	–	﹤0.01%	386
2021 Q2	$5K	Sell	100 -11	-10%	-$487	﹤0.01%	385
2021 Q1	$5K	Sell	111 -11	-9%	-$573	﹤0.01%	431
2020 Q4	$7K	Hold	122	–	–	﹤0.01%	375
2020 Q3	$5K	Sell	122 -36	-23%	-$1.34K	﹤0.01%	395
2020 Q2	$5K	Hold	158	–	–	0.01%	396
2020 Q1	$5K	Buy	158 +138	+690%	+$4.13K	0.01%	390
2019 Q4	$3K	Buy	+20	New	+$476	﹤0.01%	397

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bellevue Asset Management's NEO Position: Q2 2025 in Review

Bellevue Asset Management sold out of NeoGenomics (NEO) in Q2 2025, closing a stake of 112 shares — an estimated $1.06K sold.

Bellevue Asset Management first reported a position in NEO in Q4 2019 and held it in 17 quarters. The position peaked at $7K in Q4 2020. 274 funds tracked by Wall St. Rank hold NEO as of Q2 2025.

Bellevue Asset Management reported no remaining NeoGenomics position as of Q2 2025 after selling out during the quarter.
Bellevue Asset Management sold 112 NeoGenomics shares in Q2 2025, an estimated $1.06K.
Bellevue Asset Management first reported a position in NeoGenomics in Q4 2019 and held it in 17 quarters.
Bellevue Asset Management's NeoGenomics position peaked at $7K in Q4 2020.
274 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2025.

Based on Bellevue Asset Management's 13F filing for Q2 2025, filed 23 Jul 2025.